These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 24361163)

  • 1. Management of idiopathic pulmonary fibrosis in France: a survey of 1244 pulmonologists.
    Cottin V; Cadranel J; Crestani B; Dalphin JC; Delaval P; Israel-Biet D; Kessler R; Reynaud-Gaubert M; Valeyre D; Wallaert B; Bouquillon B; Cordier JF
    Respir Med; 2014 Jan; 108(1):195-202. PubMed ID: 24361163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey.
    Cottin V; Bergot E; Bourdin A; Cadranel J; Camus P; Crestani B; Dalphin JC; Delaval P; Dromer C; Israel-Biet D; Kessler R; Marchand-Adam S; Marquette CH; Prévot G; Reynaud-Gaubert M; Valeyre D; Wallaert B; Bouquillon B; Cordier JF
    ERJ Open Res; 2015 Oct; 1(2):. PubMed ID: 27730153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and treatment standards in idiopathic pulmonary fibrosis in the era of antifibrotic drugs in Poland: A real-world practice survey.
    Majewski S; Lewandowska K; Martusewicz-Boros MM; Piotrowski WJ
    Adv Respir Med; 2019; 87(6):221-230. PubMed ID: 31970724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating Idiopathic pulmonary fibrosis guidelines into clinical practice.
    Robalo-Cordeiro C; Morais A
    Pulmonology; 2021; 27(1):7-13. PubMed ID: 32561352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice.
    Okuda R; Hagiwara E; Baba T; Kitamura H; Kato T; Ogura T
    Respir Med; 2013 Sep; 107(9):1431-7. PubMed ID: 23849626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines.
    Cottin V; Crestani B; Valeyre D; Wallaert B; Cadranel J; Dalphin JC; Delaval P; Israel-Biet D; Kessler R; Reynaud-Gaubert M; Aguilaniu B; Bouquillon B; Carré P; Danel C; Faivre JB; Ferretti G; Just N; Kouzan S; Lebargy F; Marchand-Adam S; Philippe B; Prévot G; Stach B; Thivolet-Béjui F; Cordier JF; ;
    Eur Respir Rev; 2014 Jun; 23(132):193-214. PubMed ID: 24881074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of current practice in the diagnosis and therapy of idiopathic pulmonary fibrosis.
    Peikert T; Daniels CE; Beebe TJ; Meyer KC; Ryu JH;
    Respir Med; 2008 Sep; 102(9):1342-8. PubMed ID: 18621518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
    Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
    BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey.
    Cottin V
    Eur Respir Rev; 2014 Jun; 23(132):225-30. PubMed ID: 24881077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis.
    Costabel U; Albera C; Bradford WZ; Hormel P; King TE; Noble PW; Sahn SA; Valeyre D; du Bois RM
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):198-205. PubMed ID: 25363219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on idiopathic pulmonary fibrosis.
    Margaritopoulos GA; Giannarakis I; Siafakas NM; Antoniou KM
    Panminerva Med; 2013 Jun; 55(2):109-20. PubMed ID: 23676953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of early suspected acute exacerbations of idiopathic pulmonary fibrosis with subsequent clinical outcomes and healthcare resource utilization.
    Yu YF; Macaulay DS; Reichmann WM; Wu EQ; Nathan SD
    Respir Med; 2015 Dec; 109(12):1582-8. PubMed ID: 26607877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis.
    LaCamera PP; Limb SL; Haselkorn T; Morgenthien EA; Stauffer JL; Wencel ML
    Chron Respir Dis; 2019; 16():1479973119879678. PubMed ID: 31558049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis.
    Rammaert B; Leroy S; Cavestri B; Wallaert B; Grosbois JM
    Rev Mal Respir; 2011 Sep; 28(7):e52-7. PubMed ID: 21943547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in Japan.
    Taguchi Y; Ebina M; Hashimoto S; Ogura T; Azuma A; Taniguchi H; Kondoh Y; Suga M; Takahashi H; Nakata K; Sugiyama Y; Kudoh S; Nukiwa T;
    Respir Investig; 2015 Nov; 53(6):279-87. PubMed ID: 26521105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis.
    Arai T; Inoue Y; Sasaki Y; Tachibana K; Nakao K; Sugimoto C; Okuma T; Akira M; Kitaichi M; Hayashi S
    Respir Investig; 2014 Mar; 52(2):136-43. PubMed ID: 24636270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirfenidone treatment of idiopathic pulmonary fibrosis.
    Azuma A
    Ther Adv Respir Dis; 2012 Apr; 6(2):107-14. PubMed ID: 22333982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic pulmonary fibrosis (IPF) - common practice in Poland before the "antifibrotic drugs era".
    Piotrowski WJ; Martusewicz-Boros MM; Białas AJ; Lewandowska K
    Adv Respir Med; 2017; 85(3):136-142. PubMed ID: 28667654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of a disease severity staging classification system for IPF in Japan: 20 years of experience from empirical evidence to randomized control trial enrollment.
    Homma S; Sugino K; Sakamoto S
    Respir Investig; 2015 Jan; 53(1):7-12. PubMed ID: 25542598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of autoantibody positivity in idiopathic pulmonary fibrosis.
    Ghang B; Lee J; Chan Kwon O; Ahn SM; Oh JS; Hong S; Kim YG; Yoo B; Jeong WS; Kim J; Lee CK
    Respir Med; 2019 Aug; 155():43-48. PubMed ID: 31299466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.